MktsMarkets

Globus Medical, Inc.
NYSE: GMEDKey statistics
GMED News
Stories mentioning GMED from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 759,854 | 826,420 | 769,048 | 745,342 | 598,121 | 657,293 | 625,705 | 629,691 |
| Cost of Goods Sold | 234,066 | 261,107 | 252,533 | 248,765 | 195,397 | 263,437 | 270,515 | 260,040 |
| Gross Profit | 525,788 | 565,313 | 516,515 | 496,577 | 402,724 | 393,856 | 355,190 | 369,651 |
| Operating Expenses | ||||||||
| Research & Development | 36,510 | 36,163 | 38,067 | 39,954 | 33,062 | 33,408 | 35,380 | 37,698 |
| Sales General & Admin | 297,775 | 318,480 | 313,597 | 303,622 | 242,799 | 253,167 | 240,062 | 239,454 |
| Total Operating Expenses | 320,029 | |||||||
| Operating Income (Loss) | 150,388 | 169,340 | 137,363 | 76,109 | 97,004 | 60,274 | 48,098 | 49,622 |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | 2,247 | 391.00 | 1,537 | 772.00 | 713.00 | 1,068 | (570.00) | 997.00 |
| Pretax Income | 157,074 | 169,233 | 143,994 | 188,173 | 103,668 | 24,667 | 57,032 | 47,581 |
| Tax Provision | 32,772 | 28,639 | 25,028 | (14,673) | 28,206 | (1,838) | 5,196 | 15,821 |
| Net Income (Loss) | 124,302 | 140,594 | 118,966 | 202,846 | 75,462 | 26,505 | 51,836 | 31,760 |
| Earnings Per Share (Basic) | 0.92 | 1.04 | 0.88 | 1.50 | 0.55 | 0.20 | 0.38 | 0.23 |
| Earnings Per Share (Diluted) | 0.90 | 1.03 | 0.88 | 1.49 | 0.54 | 0.19 | 0.38 | 0.23 |
| Weighted Average Shares Outstanding (Basic) | 135,364 | 135,215 | 134,502 | 135,205 | 136,757 | 135,726 | 135,615 | 135,195 |
| Weighted Average Shares Outstanding (Diluted) | 138,191 | 137,056 | 135,394 | 136,499 | 139,774 | 137,863 | 138,062 | 136,979 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About GMED
Globus Medical, Inc. (NYSE: GMED) is a stock listed on the New York Stock Exchange under the ticker symbol GMED. It last traded at $76.37 (Nov 9, 2026, 4:00 PM ET), up 7.5% on the day. That gives Globus Medical a market capitalisation of $9.5B and a price-to-earnings ratio of 17.8.
Over the past 52 weeks GMED has traded between $60.36 and $101.40.
Revenue for the quarter ended Mar 31, 2026 was $759.9M; net income $124.3M. Revenue was up 27.0% from $598.1M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $759.9M | $124.3M | 16.4% |
| Dec 31, 2025 | $826.4M | $140.6M | 17.0% |
| Sep 30, 2025 | $769.0M | $119.0M | 15.5% |
| Jun 30, 2025 | $745.3M | $202.8M | 27.2% |
From Globus Medical’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…